ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer

Abstract

Our findings indicate that ACTL6A exhibits pro-tumor function and acts as an EMT activator in colon cancer. ACTL6A may serve as a potential therapeutic target for colon cancer.